Vincent Ossipow
InvestorPartner at Omega Funds
Switzerland
Writes $100K – $5M checks · typically $1.5M
FoundedImmunic
Experience
- Omega FundsPartnercurrent2014 — present
- Omega FundsPartner at Omega Fundscurrent2014 — presentGeneva, Switzerland - Boston
- Omega FundsPartner2014 — 2017Greater Boston
- Omega Alpha SPAC (Nasdaq OMEG)Chief Scientific Officer (CSO)current2021 — present
- Biotech - Medtech - Life Science Tool - Robotics CompaniesMember of the Board of Directorscurrent2007 — presentUnited States - Europe
- Sectoral Asset ManagementPartner Private Equity2012 — 2013
- Sectoral Asset ManagementInvestment Manager2007 — 2012
- Université de GenèveFaculty Member2000 — 2007
- Banque Pictet & Cie SAFinancial Analyst1998 — 2000
- National Cancer Institute (NCI)Postdoctoral Fellow1997 — 1998
Education
- CFA InstituteCFA Charterholder
- University of GenevaDoctor of Philosophy (Ph.D.), Molecular Biology1987 — 1996
- Georgetown UniversityCertificate, International Finance1998
Skills & more
Venture CapitalPrivate EquityValuationInvestmentsEquitiesFinancial ModelingPortfolio ManagementCapital MarketsAlternative InvestmentsAsset ManagementEquity ResearchStart-ups
- CFA
- Chartered Financial Analyst (CFA) charterholder — CFA Institute
From Vincent's professional profile.
Same school
Also attended University of Geneva43
Massimo PrelzInvestor at DN CapitalChristoph FreiPartner, Head of Energy at Emerald Technology Ventures AgErich SieberFounding General Partner at PeakBridge VCDavid MarcusInvestor at FELIX CAPITALMichelle PiontekImpact & ESG Associate at AENUPatrik BrudererCFO at CV Labs
+ 37 more
Also attended Georgetown University326
Trae StephensPartner at Founders Fund and co-founder of AndurilLuciana LixandruPartner at Sequoia CapitalKatherine BoyleGeneral Partner at Andreessen Horowitz (American Dynamism)Tobi CokerDeal Partner at Felicis VenturesAna AndreescuInvestor at Index VenturesTed LeonsisFounder & Partner, Revolution Growth at Revolution
+ 320 more
Shared employers
Also worked at Omega Funds14
Nessan BerminghamInvestor at Khosla VenturesLiam FlahertyInvestor at Silversmith Capital PartnersRichard LimManaging Partner at Cure VenturesAnnie MitsakPartner at Cure VenturesJohn MaraganoreAdvisor at Oak HC/FTPaulina HillPartner at Sanofi Ventures
+ 8 more
Also worked at Sectoral Asset Management2
Also worked at Université de Genève9
Marco PrunottoInvestor at MedicxiHadrien BouchezPartner at Kurma PartnersPeter DudekPresident at MRL Ventures FundKris KaczmarekInvestment Director at QDNL ParticipationsBenoit DubuisSwitzerland Board Member at MassChallenge MexicoAshley PilipiszynVenture Partner at Growth Warrior Capital
+ 3 more
Also worked at Banque Pictet & Cie SA9
Björn RosendahlFundraising & Growth at CV LabsDeborah PittetPartner at Forestay CapitalConnor DuffyInvestment Manager at Clean Growth FundKaren E. WilsonSenior Impact Advisor at Zebra Impact VenturesEduarde RohnerNMS Lead, Business Development at GU Ventures ABFaheem AhmedPartner at Anchorless Bangladesh
+ 3 more
Deals · 1
ImmunicBoard seat
via Omega Funds · filed Oct 2022 · $60M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Omega Funds
Alex Delbridge
Senior Associate at Omega Funds
Annie Mitsak
Partner at Cure Ventures
Benjamin Youn
Associate at Omega Funds
Bernard Davitian
Partner at Omega Funds
Claudio Nessi
Managing Director at Omega Funds
Deirdre Cunnane
COO, General Counsel at Omega Funds
Francesco Draetta
Managing Director at Omega Funds
Katie Kerfoot
Vice President at Omega Funds










%20(1).avif)




















